All In MedTech

Device Trial Radar · NCT03170583

SJM Brady MRI Post Approval Study

Last checked: Nov 20, 2026Latest source record: Jul 28, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

1,768

Actual

Start

Jun 8, 2017

Primary completion

Jun 30, 2020

Study completion Jun 30, 2020

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
May 31, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post approval study is to evaluate the long-term safety of the FDA approved St. Jude Medical Tendril MRI™ lead implanted with a SJM Brady MRI implantable pulse generator (IPG) such as the Accent MRI™, Assurity MRI™, Endurity MRI™ pacemaker, or similar model (SJM Brady MRI System) in subjects with a standard bradycardia pacing indication.

Conditions

  • Bradycardia

Interventions

  • St. Jude Medical Tendril MRI™ leadDevice

    pacemaker, leads

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from Tendril MRI RA lead-related complications through 60 months of follow upTime frame: 60 months
  2. Freedom from Tendril MRI RV lead-related complications through 60 months of follow upTime frame: 60 months
  3. MRI scan related complications rate through one-month following the MRI scanTime frame: 1 month

Locations

66 sites in 1 country. Site status is shown where the registry gives one.

  • Phoenix Cardiovascular Research Group

    Phoenix, Arizona

  • Cardiology Associates of North East Arkansas

    Jonesboro, Arkansas

  • Arkansas Heart Hospital

    Little Rock, Arkansas

63 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.